Ataxion's Series A Round

Ataxion raised a round of funding on March 17, 2014.

Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic diseases in partnership with Biogen. Ataxion is leveraging the expe…

Articles about Ataxion's Series A Round: